Early peripheral lymph node involvement of human herpesvirus 8-associated,body cavity-based lymphoma in a human immunodeficiency virus-negative patient
S. Ariad et al., Early peripheral lymph node involvement of human herpesvirus 8-associated,body cavity-based lymphoma in a human immunodeficiency virus-negative patient, ARCH PATH L, 124(5), 2000, pp. 753-755
Citations number
22
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Human herpesvirus 8 (HHV-8), or Kaposi sarcoma-associated herpesvirus, is a
gamma herpesvirus first detected in a specimen of Kaposi sarcoma from a hu
man immunodeficiency virus (HIV)-positive patient. Human herpesvirus 8 is a
lso found in an unusual clinicopathologic form of body cavity-based B-cell
lymphoma, which has been named primary effusion lymphoma (PEL) and occurs p
rimarily in HIV-positive patients. PEL is characterized by the formation of
lymphomatous effusions, without obvious lymphadenopathy, tumor masses, or
bone marrow involvement. Only a Few cases of PEL in HIV-seronegative patien
ts have been reported. We describe a case of an HHV-8-associated lymphoma,
with ascites, pleural effusion, and axillary lymphadenopathy in an HIV-nega
tive patient. The patient was a 68-year-old Jewish man of North African ext
raction, with a previous history of coronary bypass surgery and multiple bl
ood transfusions. The pleural fluid contained large atypical lymphoid cells
and was suggestive of lymphoma but could not provide a conclusive diagnosi
s of PEL. The lymph node contained groups of large anaplastic lymphoid cell
s. Polymerase chain reaction for HHV-8 performed on the lymph node specimen
was positive, establishing the diagnosis of PEL. Polymerase chain reaction
for Epstein-Barr virus was negative. Results of a gallium scan were normal
. The patient did not respond to combination chemotherapy with cyclophospha
mide, doxorubicin, vincristine sulfate, and prednisone and progressively de
veloped, massive intra-abdominal solid tumor formation. To our knowledge, t
his is the first report of a case of PEL that demonstrates peripheral lymph
node involvement at diagnosis and the first report of PEL in an Israeli pa
tient.